126 related articles for article (PubMed ID: 2632216)
1. Susceptibility of Brucella melitensis to fluoroquinolones.
Qadri SM; Akhtar M; Ueno Y; al-Sibai MB
Drugs Exp Clin Res; 1989; 15(10):483-5. PubMed ID: 2632216
[TBL] [Abstract][Full Text] [Related]
2. In vitro antimicrobial susceptibility of Brucella species.
Baykam N; Esener H; Ergönül O; Eren S; Celikbas AK; Dokuzoguz B
Int J Antimicrob Agents; 2004 Apr; 23(4):405-7. PubMed ID: 15081093
[TBL] [Abstract][Full Text] [Related]
3. Antibacterial activity of lomefloxacin against Brucella melitensis.
Qadri SM; al-Sedairy S; Ueno Y
Diagn Microbiol Infect Dis; 1990; 13(3):277-9. PubMed ID: 2383977
[TBL] [Abstract][Full Text] [Related]
4. [Short communication: Investigation of in vitro antibiotic susceptibility of Brucella melitensis].
Alişkan H; Turunç T; Demiroğlu YZ; Colakoğlu S; Arslan H
Mikrobiyol Bul; 2008 Jan; 42(1):125-9. PubMed ID: 18444570
[TBL] [Abstract][Full Text] [Related]
5. Anti-Brucella activity of Ro 23-9424, a dual-action antibacterial.
Qadri SM; Ueno Y; Ayub A
Chemotherapy; 1993; 39(6):386-9. PubMed ID: 8222864
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility of Mexican brucella isolates to moxifloxacin, ciprofloxacin and other antimicrobials used in the treatment of human brucellosis.
López-Merino A; Contreras-Rodríguez A; Migranas-Ortiz R; Orrantia-Gradín R; Hernández-Oliva GM; Gutiérrez-Rubio AT; Cardeñosa O
Scand J Infect Dis; 2004; 36(9):636-8. PubMed ID: 15370648
[TBL] [Abstract][Full Text] [Related]
7. [E-test susceptibility results of brucella strains for streptomycin, rifampicin, ciprofloxacin and tetracycline].
Sengöz G; Yaşar KK; Kutlu SB; Durdu YB; Ozdemir R; Nazlican O
Mikrobiyol Bul; 2006 Jul; 40(3):265-8. PubMed ID: 17001857
[TBL] [Abstract][Full Text] [Related]
8. Comparative in vitro activities of ofloxacin, difloxacin, ciprofloxacin, and other selected antimicrobial agents against Brucella melitensis.
Khan MY; Dizon M; Kiel FW
Antimicrob Agents Chemother; 1989 Aug; 33(8):1409-10. PubMed ID: 2802568
[TBL] [Abstract][Full Text] [Related]
9. A multicenter study on the comparative in vitro activity of fleroxacin and three other quinolones: an interim report from 27 centers.
Beskid G; Prosser BL
Am J Med; 1993 Mar; 94(3A):2S-8S. PubMed ID: 8383919
[TBL] [Abstract][Full Text] [Related]
10. [Determination of in vitro susceptibilities of Brucella spp. strains against 11 different antibacterial gents isolated from blood cultures].
Keşli R; Bilgin H; Yılmaz H
Mikrobiyol Bul; 2017 Jul; 51(3):260-268. PubMed ID: 28929962
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility of Brucella melitensis to the new fluoroquinolone PD 131628: comparison with other drugs.
Qadri SM; Ueno Y
Chemotherapy; 1993; 39(2):128-31. PubMed ID: 8384544
[TBL] [Abstract][Full Text] [Related]
12. In vitro activities of various antimicrobials against Brucella melitensis strains in the Aegean region in Turkey.
Yamazhan T; Aydemir S; Tünger A; Serter D; Gökengin D
Med Princ Pract; 2005; 14(6):413-6. PubMed ID: 16220015
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of eight fluoroquinolones against clinical isolates of Brucella melitensis.
Qadri SM; Akhter J; Ueno Y; Saldin H
Ann Saudi Med; 1993 Jan; 13(1):37-40. PubMed ID: 17587989
[TBL] [Abstract][Full Text] [Related]
14. The frequency of in vitro resistance to fluoroquinolones among clinical isolates of Escherichia coli.
Poiată A; Bădicuţ I; Grigore L; Buiuc D
Roum Arch Microbiol Immunol; 2000; 59(1-2):63-9. PubMed ID: 11845477
[TBL] [Abstract][Full Text] [Related]
15. In-vitro activity of ciprofloxacin, ceftriaxone and five other antimicrobial agents against 95 strains of Brucella melitensis.
Bosch J; Liñares J; López de Goicoechea MJ; Ariza J; Cisnal MC; Martin R
J Antimicrob Chemother; 1986 Apr; 17(4):459-61. PubMed ID: 2940209
[TBL] [Abstract][Full Text] [Related]
16. [In vitro determination of the sensitivity of mycobacteria to fluoroquinolones].
Dailloux M; Petitpain N; Henry C; Weber M
Pathol Biol (Paris); 1989 May; 37(5):346-9. PubMed ID: 2780092
[TBL] [Abstract][Full Text] [Related]
17. [In vitro evaluation of lomefloxacin].
Dette GA; Knothe H
Arzneimittelforschung; 1989 Aug; 39(8):832-5. PubMed ID: 2818672
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of Brucella melitensis isolates to various antimicrobials in Turkey.
Denk A; Demirdag K; Kalkan A; Ozden M; Cetinkaya B; Kilic SS
Infect Dis (Lond); 2015 Jun; 47(6):364-9. PubMed ID: 25712728
[TBL] [Abstract][Full Text] [Related]
19. Seroepidemiological and microbiological study of brucellosis in Kuwait.
Dimitrov Ts; Panigrahi D; Emara M; Awni F; Passadilla R
Med Princ Pract; 2004; 13(4):215-9. PubMed ID: 15181327
[TBL] [Abstract][Full Text] [Related]
20. Identification of Brucella species isolated from proven brucellosis patients in Izmir, Turkey.
Köse S; Kiliç S; Ozbel Y
J Basic Microbiol; 2005; 45(4):323-7. PubMed ID: 16028204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
